PharmaMedic /
  • Home
  • Our Services
    • Start-Up
    • Product Launch
    • Product Development
  • Join Us
  • About Us
    • Our Vision
    • Dr Malcolm Barratt-Johnson
  • Resources
  • News
  • Contact Us
PharmaMedic
  • Home
  • Our Services
    • Start-Up
    • Product Launch
    • Product Development
  • Join Us
  • About Us
    • Our Vision
    • Dr Malcolm Barratt-Johnson
  • Resources
  • News
  • Contact Us

#ABPI

Tag

Public and HCP trust in UK pharma industry maintained

Public and HCP trust in UK pharma industry maintained

The third annual Pharma Reputation Index, commissioned by the Association of the British Pharmaceutical Industry (ABPI), has found that the public looks favourably on the industry and continues to recognise its commitment to developing new medicines.

7 Sep 2023
Read More
Pharma organisations tussle over VPAS negotiations

Pharma organisations tussle over VPAS negotiations

A High Court judgment on a judicial review brought by the British Generic Manufacturers Association (BGMA) has dismissed the organisation’s claim that it was unfairly excluded from talks on the next Voluntary Scheme for Branded Medicines Pricing and Access (VPAS).

20 Jul 2023
Read More
International investment in UK life sciences plummets

International investment in UK life sciences plummets

Figures from the ninth annual life sciences competitiveness indicators (LSCIs) report show that in 2022 the UK saw a substantial drop in foreign investment in its life sciences, compared to 2021. It fell to £1 billion from £1.9 billion, a drop of 47%. This saw the UK move down to ninth out of 18 comparator countries in 2021, from second place in 2021.

19 Jul 2023
Read More
ABPI report highlights skills gaps

ABPI report highlights skills gaps

A report by the Association of the British Pharmaceutical Industry (ABPI) shows an ongoing need for AI, digital and data talent to support innovative drug discovery and development. The report, ‘Evolution of an innovation-based biopharmaceutical industry’, published on 8 June 2023, is updated every two years and investigates the latest trends and skills requirements for the life sciences industry in the UK.

12 Jun 2023
Read More
Award for PharmaMedic’s Managing Director

Award for PharmaMedic’s Managing Director

We are excited to report that PharmaMedic's Managing Director, Dr Malcolm Barratt-Johnson has received a Global Fellow in Medicines Development (GFMD) award from the respected GMDP Academy.

1 Jun 2023
Read More
Will ABPI’s ambitious VPAG plans succeed VPAS?

Will ABPI’s ambitious VPAG plans succeed VPAS?

Discussions are beginning on the next iteration of the UK’s voluntary scheme for branded medicines, pricing and access (VPAS) and the Association of the British Pharmaceutical Industry (ABPI) has set out its stall to government. It has published a four-point proposal for a Voluntary Scheme for Pricing, Access and Growth (VPAG), designed to reignite competitiveness and boost innovation in the life sciences sector, thereby improving health outcomes and the wider economy.

15 May 2023
Read More
The 2023 ABPI annual conference focused on growing the Life Sciences

The 2023 ABPI annual conference focused on growing the Life Sciences

The 2023 annual conference of the UK’s Association of the British Pharmaceutical Industry (ABPI) at the end of April had a theme of Growing the UK as a Global Hub for Life Sciences.

9 May 2023
Read More
Government confirms increase to pharma’s statutory scheme

Government confirms increase to pharma’s statutory scheme

Despite opposition from the Association of the British Pharmaceutical Industry (ABPI), the UK government has confirmed its plans to raise the revenue clawback rate paid by pharma for branded medicines under the statutory scheme by just over 3%, from 24.4% to 27.5% for 2023.

9 Mar 2023
Read More
ABPI asks UK government to review VPAS as clawback will hit 26.5% of sales revenue in 2023

ABPI asks UK government to review VPAS as clawback will hit 26.5% of sales revenue in 2023

In 2023 manufacturers of branded medicines will be required to return almost £3.3bn in sales revenue to the government under the 2019 Voluntary scheme for branded medicines, pricing and access (VPAS), according to the Association of the British Pharmaceutical Industry (ABPI).

20 Dec 2022
Read More
ABPI report warns UK is losing its global standing in clinical trials

ABPI report warns UK is losing its global standing in clinical trials

ABPI report warns UK is losing its global standing in clinical trials. The research ‘Rescuing Patient Access to Industry Clinical Trials in the UK’ shows that the number of industry clinical trials initiated in the UK per year fell by 41% between 2017 and 2021, with cancer trials falling by the same margin.

31 Oct 2022
Read More

Categories

  • Awards
  • Consultants
  • Events
  • News
    • General
    • Medical Affairs
    • Rare diseases
  • Our Services
  • Regulatory
  • Resources
    • White Paper

Tags

#ABPI #BIA #cancer #ClinicalTrials #drugapprovals #drugpricing #drugregulation #EC #EFPIA #EMA #EU #FDA #HorizonEurope #HTA #innovation #lifesciences #marketaccess #MDR #medicalaffairs #medicaldevice #medicinesaccess #medtech #mentalhealth #mhra #NHS #NICE #patients #pharmaregulation #pre-eclampsia #R&D #rarediseases #regulation #regulatory #research #startups #UKgovernment #ukpharma #ukregulation #VPAS AI Biotech COVID-19 Healthcare medicaldevices Pharma
PharmaMedic
  • Home
  • Join Us
  • Our Vision
  • Dr Malcolm Barratt-Johnson
  • Resources
  • News
  • Contact Us
Our Services
  • Start-Up
  • Product Launch
  • Product Development
Legal
  • Privacy Policy
  • Cookie Policy
Contact us
  • T:+44 (0) 208 168 1668
  • US Toll Free:+1 628 201 0911
  • [javascript protected email address]
  • The London Bioscience Innovation Centre (LBIC)
    2 Royal College Street
    London NW1 0NH

©2023 PharmaMedic. All Rights Reserved | Company Registration Number: 07364364 | VAT: 135986768

Powered by FL1 Digital